{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:43:09Z","timestamp":1700613789000},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pancreatic cancer is a devastating disease with less than 5% 5-year survival. Inoperable patients often present with pain. Randomized controlled trial have shown that endoscopic ultrasound-guided celiac plexus neurolysis (EUS-CPN) improves pain control. It is usually performed by injecting bupivacaine followed by absolute alcohol around the celiac axis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Study design<\/jats:title>\n                <jats:p>Single center, randomized, double blind controlled trial of EUS-CPN with and without bupivacaine in patients with inoperable malignancy (pancreatic or other) involving the celiac plexus. The study was approved by research ethics board with approval number of 2022-9969, 21.151 and registered on ClinicalTrials.gov (NCT04951804).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>We hypothesize that bupivacaine is superfluous and may actually reduce pain control by diluting the neurolytic effect of alcohol. Bupivacaine is also potentially dangerous in that it may produce serious adverse events such as arrythmias and cardiac arrest if inadvertently injected intravascularly.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This randomized trial is designed to assess whether bupivacaine is of any value during EUS-CPN.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-023-07487-7","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T10:01:52Z","timestamp":1694167312000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Protocol for a randomized controlled trial of endoscopic ultrasound guided celiac plexus neurolysis (EUS-CPN) with vs without bupivacaine"],"prefix":"10.1186","volume":"24","author":[{"given":"Eslam","family":"Esmail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarto C","family":"Paquin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand V","family":"Sahai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,8]]},"reference":[{"issue":"1","key":"7487_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14740\/wjon1166","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10(1):10\u201327.","journal-title":"World J Oncol"},{"issue":"5","key":"7487_CR2","first-page":"356","volume":"5","author":"RB Reynolds","year":"2014","unstructured":"Reynolds RB, Folloder J. Clinical management of pancreatic cancer. J Adv Pract Oncol. 2014;5(5):356\u201364.","journal-title":"J Adv Pract Oncol"},{"issue":"22","key":"7487_CR3","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1200\/JCO.2016.67.5561","volume":"34","author":"EP Balaban","year":"2016","unstructured":"Balaban EP, Mangu PB, Khorana AA, Shah MA, Mukherjee S, Crane CH, et al. Locally advanced, unresectable pancreatic cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2016;34(22):2654\u201368.","journal-title":"J Clin Oncol"},{"issue":"26","key":"7487_CR4","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1200\/JCO.2010.32.2750","volume":"29","author":"JM Wyse","year":"2011","unstructured":"Wyse JM, Carone M, Paquin SC, et al. Randomized, double-blind, controlled trial of early endoscopic ultrasound-guided celiac plexus neurolysis to prevent pain progression in patients with newly diagnosed, painful, inoperable pancreatic cancer. J Clin Oncol. 2011;29(26):3541\u20136.","journal-title":"J Clin Oncol"},{"issue":"4","key":"7487_CR5","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cgh.2018.08.040","volume":"17","author":"MJ Levy","year":"2019","unstructured":"Levy MJ, Gleeson FC, Topazian MD, Fujii-Lau LL, Enders FT, et al. Combined celiac ganglia and plexus neurolysis shortens survival, without benefit, vs plexus neurolysis alone. Clin Gastroenterol Hepatol. 2019;17(4):728\u2013738.e9.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"7487_CR6","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/SLE.0000000000000683","volume":"29","author":"S Lou","year":"2019","unstructured":"Lou S. Endoscopic ultrasound-guided celiac plexus neurolysis to alleviate intractable pain caused by advanced pancreatic cancer. Surg Laparosc Endosc Percutan Tech. 2019;29(6):472\u20135.","journal-title":"Surg Laparosc Endosc Percutan Tech"},{"issue":"6","key":"7487_CR7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.4103\/eus.eus_97_17","volume":"6","author":"JM Wyse","year":"2017","unstructured":"Wyse JM, Battat R, Sun S, et al. Practice guidelines for endoscopic ultrasound-guided celiac plexus neurolysis. Endosc Ultrasound. 2017;6(6):369\u201375.","journal-title":"Endosc Ultrasound"},{"issue":"3","key":"7487_CR8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S0750-7658(88)80112-6","volume":"7","author":"JJ Eledjam","year":"1988","unstructured":"Eledjam JJ, de la Coussaye JE, Bassoul B, Brugada J. M\u00e9canismes de la toxicit\u00e9 cardiaque de la bupivaca\u00efne. Annales Fran\u00e7aises d\u2019Anesth\u00e9sie et de R\u00e9animation. 1988;7(3):204\u201310. https:\/\/doi.org\/10.1016\/S0750-7658(88)80112-6.","journal-title":"Annales Fran\u00e7aises d\u2019Anesth\u00e9sie et de R\u00e9animation"},{"key":"7487_CR9","doi-asserted-by":"publisher","first-page":"e7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"A-W Chan","year":"2013","unstructured":"Chan A-W, Tetzlaff JM, G\u00f8tzsche PC, Altman DG, Mann H, Berlin J, Dickersin K, Hr\u00f3bjartsson A, Schulz KF, Parulekar WR, Krle\u017ea-Jeri\u0107 K, Laupacis A, Moher D. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.","journal-title":"BMJ"},{"issue":"3","key":"7487_CR10","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.gie.2009.10.027","volume":"71","author":"PB Cotton","year":"2010","unstructured":"Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010;71(3):446\u201354.","journal-title":"Gastrointest Endosc"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07487-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07487-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07487-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T12:27:42Z","timestamp":1700569662000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07487-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,8]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7487"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07487-7","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,8]]},"assertion":[{"value":"17 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent for publication was obtained with informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"576"}}